Disagreement over the international reach of drug patents has emerged as a significant challenge as the Obama administration tries to hatch a Pacific trade deal acceptable to U.S. companies, political factions in Congress and trading partners.

The issue flared last week as half a dozen senators grilled U.S. Trade Representative Michael Froman about his commitment to rules that would protect medicines called biologic drugs from...